Filing Details
- Accession Number:
- 0001562180-19-002780
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-13 16:11:52
- Reporting Period:
- 2019-05-09
- Accepted Time:
- 2019-05-13 16:11:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1654430 | Briggs Morrison | C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-09 | 13,200 | $7.56 | 13,200 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-13 | 7,200 | $7.29 | 20,400 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchase prices ranged from $7.50 to $7.60.